Evidence map›Paper›PMID 9632757›Full record

ArticleMolecular and cellular biology1998

Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression.

P R Mittelstadt, J D Ashwell

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 163 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. The Immediate Early GeneFrontiers in behavioral neuroscience · 2018
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapine.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2012
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Adenosine A2A receptor activation protects CD4+ T lymphocytes against activation-induced cell death.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2010
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

P R MittelstadtLaboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1152, USA.
J D Ashwell
National Cancer Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Activation-induced transcriptional upregulation of the ligand for Fas (FasL) and the resulting apoptosis of Fas-bearing cells constitute essential steps in a host of normal and pathological processes. Here we describe an activation-inducible cis-acting regulatory element in the fasL promoter that is required for gene expression. Oligonucleotide competition and antibody supershift analyses identified two activation-induced DNA-binding species: Egr-1 (NGFI-A, krox-24, zif268, TIS-8), a transcription factor that has been implicated in growth, differentiation, and apoptosis; and Egr-3 (PILOT), a transcription factor of no previously known function. Activation-induced expression of Egr-3, like that of FasL, was inhibited by cyclosporin A, whereas expression of Egr-1 was unaffected. Transient expression of Egr-3 alone increased fasL promoter activity in a cyclosporin A-insensitive manner, whereas expression of Egr-1 had little effect. Moreover, endogenous fasL mRNA was induced in nonlymphoid cells by forced expression of Egr-3 in the absence of any other stimulus. These studies identify a critical Egr family-binding site in the fasL promoter and demonstrate that activation-induced Egr-3, but not Egr-1, directly upregulates fasL transcription in response to activating stimuli.

Indexed as

Transcriptional ActivationAnimalsCyclosporineDNA-Binding ProteinsEarly Growth Response Protein 3Fas Ligand ProteinGene Expression RegulationHeLa CellsHumansMembrane GlycoproteinsMicePromoter Regions, GeneticReceptors, Antigen, T-CellTranscription FactorsTumor Cells, CulturedCyclosporineDNA-Binding ProteinsEarly Growth Response Protein 3Egr3 protein, mouseFASLG protein, humanFas Ligand ProteinFasl protein, mouseMembrane GlycoproteinsReceptors, Antigen, T-CellTranscription Factors

Identifiers

PMID9632757
PMCPMC108957
OpenAlexW2159266018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.